Most lethal mutations in wild fruit flies are driven by newly transferred jumping genes, not small DNA errors, according to a new study from Duke University. The findings, published in PLOS Biology, ...

Scientists have developed an AI system that analyzes complex gene-expression signatures to estimate the likelihood that a tumor will spread.

At UTMB Health, every day brings new possibilities for patients like Max—a young man living with Duchenne muscular dystrophy. This rare genetic condition causes muscles to weaken over time, but thanks ...

South Alabama has added nine football players through the transfer portal, school officials announced Wednesday. Among the group of newcomers are two offensive linemen, a tight end, three defensive ...

New York City FC head coach Pascal Jansen had no interest in getting into a back-and-forth after Schalke sporting director Frank Baumann released a scathing statement after the transfer of Moussa ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...

The study, published in Genomic Psychiatry, identified how stress hormones activate specific RNA molecules called long noncoding RNAs, or IncRNAs, that interact with the gene-silencing complex PRC2, ...

No one had to tell Bob Chesney about his needs in the transfer portal. Offensive linemen. Defensive linemen. Wide receivers. Tight ends. Linebackers. Defensive backs. A running back. A backup ...

With the commitment of former Georgia tight end Pearce Spurlin late last week, a total of five players at that position are part of the Rams’ 2026 transfer class. Spurlin joins former UConn Huskies ...

The NCAA football transfer portal window is officially closed for 2026. That doesn’t mean there won’t be some movement – anybody already in the national database is free to return to their old program ...

Troy has officially added 14 football players through the transfer portal, school officials announced Saturday. Among the group of newcomers are one running back, one wide receiver, three offensive ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may outperform existing treatments from Apellis Pharmaceuticals and Astellas ...